Clinical Trial Update: Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dose proportionality of a fixed-dose combination of COREG CR (carvedilol CR) and lisinopril for hypertension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)
• Lisinopril (Lisinopril)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED